Related Experiment Video
Updated: Dec 10, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Targeting the GRP78 Pathway for Cancer Therapy
Guanhua Lu1, Hui Luo1,2,3,4, Xiao Zhu1,2,3,4
1Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.
The 78-kDa glucose-regulated protein (GRP78) is crucial for protein stability and organ function. Research highlights its role in tumor targeted therapy and response to endoplasmic reticulum stress, impacting cell survival and proliferation.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The 78-kDa glucose-regulated protein (GRP78) is vital for protein stability, folding, and autophagy.
- GRP78 also plays a significant role in maintaining normal organ function.
- Its involvement in endoplasmic reticulum stress (ERS) is critical for cell survival.
Purpose of the Study:
- To explore the targeted therapy of GRP78, particularly in cancer.
- To elucidate GRP78's function as a key modulator in cellular pathways.
- To understand the impact of GRP78 expression changes on cell proliferation, apoptosis, and organ protection.
Main Methods:
- Literature review of recent research on GRP78.
- Analysis of GRP78's role in endoplasmic reticulum stress response.
- Investigation of GRP78's modulation of subordinate pathways.
Main Results:
- GRP78 is a powerful protein involved in protein homeostasis and organ function.
- Targeted therapy of GRP78 is a growing area of research, especially in oncology.
- GRP78's response to ERS influences tumor cell survival and proliferation.
Conclusions:
- GRP78 is a critical factor in cellular responses to stress and disease.
- Understanding GRP78's function is key for developing novel therapeutic strategies.
- Modulating GRP78 expression can impact cell fate and organ protection.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation